INmune Bio Inc. and Quantum Computing Inc. Partner to Apply Quantum Optimization and AI to Advance Alzheimer's Drug Research and Explore New Applications for XPro ™
<p>Collaboration combines INmune Bio's clinical research with QCi's Dirac-3S quantum optimization machine to identify potential new treatment indications and biomarkers for XPro Initial engagement marks QCi's first commercial customer in pharmaceutical and biotechnology markets, expanding...</p>
Read original article ↗
Related Articles
Huawei's NG WAN Solution Enters Large-Scale Commercial Use to Drive Carrier Growth
VIENNA, Oct. 14, 2026 /PRNewswire/ -- On October 13, at the Net5.5G Intelligent IP Network Summit during UBBF 2026, John
The new platform brings together advanced analysis, purpose-built AI, and curated biological data so researchers can mov
Nearly seven in 10 organizations have invested at least $250,000 in AI over the past two years, but more leaders see gai
xFusion at OCP 2026: When Cooling, Power, and Interconnect Converge for the Agentic Era
Keynote and three product showcases address the cooling, power, and interconnect challenges defining next-generation AI